Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
- PMID: 33293339
- PMCID: PMC7857406
- DOI: 10.1126/science.abe9728
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly in Manaus, the capital of Amazonas state in northern Brazil. The attack rate there is an estimate of the final size of the largely unmitigated epidemic that occurred in Manaus. We use a convenience sample of blood donors to show that by June 2020, 1 month after the epidemic peak in Manaus, 44% of the population had detectable immunoglobulin G (IgG) antibodies. Correcting for cases without a detectable antibody response and for antibody waning, we estimate a 66% attack rate in June, rising to 76% in October. This is higher than in São Paulo, in southeastern Brazil, where the estimated attack rate in October was 29%. These results confirm that when poorly controlled, COVID-19 can infect a large proportion of the population, causing high mortality.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures


Comment in
-
Herd immunity by infection is not an option.Science. 2021 Jan 15;371(6526):230-231. doi: 10.1126/science.abf7921. Science. 2021. PMID: 33446540 No abstract available.
References
-
- Hallal P. C., Hartwig F. P., Horta B. L., Silveira M. F., Struchiner C. J., Vidaletti L. P., Neumann N. A., Pellanda L. C., Dellagostin O. A., Burattini M. N., Victora G. D., Menezes A. M. B., Barros F. C., Barros A. J. D., Victora C. G., SARS-CoV-2 antibody prevalence in Brazil: Results from two successive nationwide serological household surveys. Lancet Glob. Health 8, e1390–e1398 (2020). 10.1016/S2214-109X(20)30387-9 - DOI - PMC - PubMed
-
- Candido D. da S., Claro I. M., de Jesus J. G., Souza W. M., Moreira F. R. R., Dellicour S., Mellan T. A., du Plessis L., Pereira R. H. M., Sales F. C. S., Manuli E. R., Thézé J., Almeida L., Menezes M. T., Voloch C. M., Fumagalli M. J., Coletti T. M., da Silva C. A. M., Ramundo M. S., Amorim M. R., Hoeltgebaum H. H., Mishra S., Gill M. S., Carvalho L. M., Buss L. F., Prete C. A., Ashworth J., Nakaya H. I., Peixoto P. S., Brady O. J., Nicholls S. M., Tanuri A., Rossi Á. D., Braga C. K. V., Gerber A. L., Guimarães A. P. de C., Gaburo N., Alencar C. S., Ferreira A. C. S., Lima C. X., Levi J. E., Granato C., Ferreira G. M., Francisco R. S., Granja F., Garcia M. T., Moretti M. L., Perroud M. W., Castiñeiras T. M. P. P., Lazari C. S., Hill S. C., de Souza-Santos A. A., Simeoni C. L., Forato J., Sposito A. C., Schreiber A. Z., Santos M. N. N., de Sá C. Z., Souza R. P., Resende-Moreira L. C., Teixeira M. M., Hubner J., Leme P. A. F., Moreira R. G., Nogueira M. L., Brazil-UK Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE) Genomic Network, Ferguson N. M., Costa S. F., Proenca-Modena J. L., Vasconcelos A. T. R., Bhatt S., Lemey P., Wu C.-H., Rambaut A., Loman N. J., Aguiar R. S., Pybus O. G., Sabino E. C., Faria N. R., Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science 369, 1255–1260 (2020). 10.1126/science.abd2161 - DOI - PMC - PubMed
-
- de Souza W. M., Buss L. F., Candido D. da S., Carrera J.-P., Li S., Zarebski A. E., Pereira R. H. M., Prete C. A. Jr.., de Souza-Santos A. A., Parag K. V., Belotti M. C. T. D., Vincenti-Gonzalez M. F., Messina J., da Silva Sales F. C., Andrade P. D. S., Nascimento V. H., Ghilardi F., Abade L., Gutierrez B., Kraemer M. U. G., Braga C. K. V., Aguiar R. S., Alexander N., Mayaud P., Brady O. J., Marcilio I., Gouveia N., Li G., Tami A., de Oliveira S. B., Porto V. B. G., Ganem F., de Almeida W. A. F., Fantinato F. F. S. T., Macário E. M., de Oliveira W. K., Nogueira M. L., Pybus O. G., Wu C.-H., Croda J., Sabino E. C., Faria N. R., Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nat. Hum. Behav. 4, 856–865 (2020). 10.1038/s41562-020-0928-4 - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous